Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.

MLA

Neeland, Ian J., et al. “Relation of Plasma Ceramides to Visceral Adiposity, Insulin Resistance and the Development of Type 2 Diabetes Mellitus: The Dallas Heart Study.” Diabetologia, vol. 61, no. 12, Dec. 2018, pp. 2570–79. EBSCOhost, https://doi.org/10.1007/s00125-018-4720-1.

APA

Neeland, I. J., Singh, S., McGuire, D. K., Vega, G. L., Roddy, T., Reilly, D. F., Castro-Perez, J., Kozlitina, J., & Scherer, P. E. (2018). Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia, 61(12), 2570–2579. https://doi.org/10.1007/s00125-018-4720-1

Chicago

Neeland, Ian J, Shruti Singh, Darren K McGuire, Gloria L Vega, Thomas Roddy, Dermot F Reilly, Jose Castro-Perez, Julia Kozlitina, and Philipp E Scherer. 2018. “Relation of Plasma Ceramides to Visceral Adiposity, Insulin Resistance and the Development of Type 2 Diabetes Mellitus: The Dallas Heart Study.” Diabetologia 61 (12): 2570–79. doi:10.1007/s00125-018-4720-1.